Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Arabidopsis thaliana | 3-ketoacyl-CoA synthase 18 | Starlite/ChEMBL | References |
Arabidopsis thaliana | 3-ketoacyl-CoA synthase 20 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Giardia lamblia | Fatty acid elongase 1 | Get druggable targets OG5_130146 | All targets in OG5_130146 |
Entamoeba histolytica | fatty acid elongase, putative | Get druggable targets OG5_130146 | All targets in OG5_130146 |
Entamoeba histolytica | fatty acid elongase, putative | Get druggable targets OG5_130146 | All targets in OG5_130146 |
Entamoeba histolytica | fatty acid elongase, putative | Get druggable targets OG5_130146 | All targets in OG5_130146 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | roundabout 2 | 0.0017 | 0.01 | 0.0173 |
Schistosoma mansoni | tyrosine kinase | 0.0169 | 0.5819 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.01 | 0.3216 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.01 | 0.3216 | 0.5 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.016 | 0.5485 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.01 | 0.017 |
Schistosoma mansoni | tyrosine kinase | 0.0055 | 0.1529 | 0.2627 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0169 | 0.5819 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.01 | 0.3216 | 0.5 |
Echinococcus granulosus | insulin receptor | 0.0055 | 0.1529 | 0.2627 |
Echinococcus multilocularis | 0.0052 | 0.143 | 0.2325 | |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0091 | 0.2902 | 0.4899 |
Giardia lamblia | Fatty acid elongase 1 | 0.0181 | 0.6263 | 0.5 |
Echinococcus multilocularis | insulin receptor | 0.0055 | 0.1529 | 0.2498 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0169 | 0.5819 | 1 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0171 | 0.5906 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.01 | 0.3216 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.028 | 1 | 1 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0169 | 0.5819 | 0.9801 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.01 | 0.3216 | 0.5 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0091 | 0.2902 | 0.4987 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.01 | 0.3216 | 0.5 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0055 | 0.1529 | 0.2589 |
Schistosoma mansoni | tyrosine kinase | 0.0089 | 0.283 | 0.4864 |
Entamoeba histolytica | fatty acid elongase, putative | 0.028 | 1 | 1 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0055 | 0.1529 | 0.2627 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.01 | 0.017 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0169 | 0.5819 | 0.9853 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0055 | 0.1529 | 0.2498 |
Schistosoma mansoni | tyrosine kinase | 0.0091 | 0.2902 | 0.4987 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0146 | 0.495 | 0.4253 |
Schistosoma mansoni | tyrosine kinase | 0.0091 | 0.2902 | 0.4987 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0146 | 0.495 | 0.4253 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0091 | 0.2902 | 0.4987 |
Schistosoma mansoni | tyrosine kinase | 0.0089 | 0.283 | 0.4864 |
Schistosoma mansoni | tyrosine kinase | 0.0055 | 0.1529 | 0.2627 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.01 | 0.3216 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0171 | 0.5906 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.01 | 0.3216 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0089 | 0.283 | 0.4864 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | Growth inhibition of Saccharomyces cerevisiae INVSc1 at 100 uM after 18 to 20 hr | ChEMBL. | 15277688 | |
Activity (functional) | Herbicidal activity against Arabidopsis thaliana assessed as apperance of fiddle head phenotype | ChEMBL. | 15277688 | |
IC50 (binding) | = 5.7 | Inhibition of Arbidopsis thaliana C-terminal His-tagged At5g43760 expressed in Saccharomyces cerevisiae INVSc1 after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 |
IC50 (binding) | = 7.1 | Inhibition of Arbidopsis thaliana C-terminal His-tagged FAE1 expressed in Saccharomyces cerevisiae INVSc1 after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 |
Inhibition (binding) | Inhibition of Arbidopsis thaliana C-terminal His-tagged CER60 expressed in Saccharomyces cerevisiae INVSc1 at 100 uM after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 | |
Inhibition (binding) | Inhibition of Arbidopsis thaliana C-terminal His-tagged KCS1 expressed in Saccharomyces cerevisiae INVSc1 at 100 uM after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 | |
Inhibition (binding) | Inhibition of Arbidopsis thaliana C-terminal His-tagged At5g43760 expressed in Saccharomyces cerevisiae INVSc1 at 100 uM after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 | |
Inhibition (binding) | Inhibition of Arbidopsis thaliana C-terminal His-tagged KCS2 expressed in Saccharomyces cerevisiae INVSc1 at 100 uM after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 | |
Inhibition (binding) | Inhibition of Arbidopsis thaliana C-terminal His-tagged At1g04220 expressed in Saccharomyces cerevisiae INVSc1 at 100 uM after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 | |
Inhibition (binding) | Inhibition of Arbidopsis thaliana C-terminal His-tagged FAE1 expressed in Saccharomyces cerevisiae INVSc1 at 100 uM after 18 to 20 hr by GC/MS analysis | ChEMBL. | 15277688 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.